Edwards Lifesciences Corp
BMV:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
BMV:EW
Watchlist
Price: 2 140.4299 MXN -0.1% Market Closed
Market Cap: Mex$66.4B

Operating Margin

27.7%
Current
Declining
by 1.9%
vs 3-y average of 29.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
27.7%
=
Operating Income
$1.6B
/
Revenue
$5.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
27.7%
=
Operating Income
Mex$1.6B
/
Revenue
$5.9B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.5B USD
Loading...

Market Distribution

Higher than 88% of companies in the United States of America
Percentile
88th
Based on 14 112 companies
88th percentile
27.7%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Edwards Lifesciences Corp
Glance View

Nestled at the intersection of medical innovation and patient care, Edwards Lifesciences Corp. has long been a pioneer in the field of heart disease solutions. Emerging from its origins in the 1950s, the company has consistently focused on advancing heart valve technology, a critical area given the prevalence and severity of cardiovascular diseases. Their journey began with the development of the first artificial heart valve, setting a foundation of innovation that continues to propel the company forward. Today, Edwards is renowned for its leadership in transcatheter aortic valve replacement (TAVR) technology, an area that revolutionizes the treatment of aortic stenosis, a condition that narrows heart valves and impedes blood flow. This shift from open-heart surgeries to less invasive procedures, facilitated by Edwards' products, has marked a significant turning point in patient care, minimizing recovery times and enhancing patient outcomes. Financially, Edwards Lifesciences thrives on a robust business model centered around its technologically advanced heart valve systems and critical care technologies. The company operates through a direct sales force as well as strategic partnerships, ensuring their devices reach hospitals and healthcare providers globally. Their commitment to research and development ensures a steady pipeline of innovative products, which not only differentiates them in the market but also drives their profitability. Revenue streams are primarily fueled by the sales of their TAVR systems, surgical heart valves, and monitoring technologies—each designed to meet the complex and evolving needs of patients with structural heart diseases. By continually investing in cutting-edge technology and expanding their global reach, Edwards Lifesciences not only supports its bottom line but also positions itself as a leader in the transformative field of medical device innovation.

EW Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
27.7%
=
Operating Income
$1.6B
/
Revenue
$5.9B
What is Edwards Lifesciences Corp's current Operating Margin?

The current Operating Margin for Edwards Lifesciences Corp is 27.7%, which is below its 3-year median of 29.6%.

How has Operating Margin changed over time?

Over the last 3 years, Edwards Lifesciences Corp’s Operating Margin has decreased from 32.8% to 27.7%. During this period, it reached a low of 27.2% on Dec 31, 2024 and a high of 35.3% on Dec 31, 2022.

Back to Top